NEW
YORK, June 19, 2025 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders
of Organon & Co. (NYSE: OGN).
Shareholders who purchased shares of OGN during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=153522&from=4
CLASS PERIOD: October 31,
2024 to April 30, 2025
ALLEGATIONS: According to the complaint, defendants
provided overwhelmingly positive statements to investors while, at
the same time, disseminating materially false and misleading
statements and/or concealing material adverse facts concerning the
true state of Organon's priorities, particularly, related to
capital allocation through quarterly dividends. Notably, defendants
concealed the high priority of Organon's debt reduction strategy
following the Company's acquisition of Dermavant, resulting in a
70% decrease for the regular quarterly dividend.
Following this news, the price of Organon's common stock declined
dramatically. From a closing market price of $12.93 per share on April
30, 2025, Organon's stock price fell to $9.45 per share on May 1,
2025, a decline of more than 27% in the span of just a
single day.
DEADLINE: July 22, 2025
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=153522&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of OGN during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is July 22, 2025. There is no cost or obligation to
you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/investors-who-lost-money-on-organon--coogn-should-contact-the-gross-law-firm-about-pending-class-action---ogn-302485896.html
SOURCE The Gross Law Firm
